• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性血小板减少症及多次输血患者中的高聚集效应。

Hyperaggregation effect in idiopathic thrombocytopenia and multiple transfused patients.

作者信息

Wagner N, Degnan T J

出版信息

J Clin Pathol. 1973 Sep;26(9):697-9. doi: 10.1136/jcp.26.9.697.

DOI:10.1136/jcp.26.9.697
PMID:4752412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC477854/
Abstract

A new technique for detecting platelet antibodies was investigated. The serum from patients having platelet antibodies was added to normal group O compatible pooled platelet-rich plasma. Platelet aggregation induced by adrenaline and adenosine diphosphate (ADP) was significantly increased as compared to the identical platelet-rich plasma without serum. The platelet-rich plasma with serum added did not aggregate spontaneously. When an alpha-adrenergic blocking agent (tolazoline) was added, the primary wave of aggregation induced by adrenaline was equally reversed with platelet-rich plasma, with or without serum. Although platelet antibodies by themselves did not agglutinate platelets in our test system, it is probable that platelet antibodies interact with platelets and potentiate their ability to aggregate. It is suggested that the platelet aggregometer is a useful tool for the detection of platelet antibodies in vitro.

摘要

研究了一种检测血小板抗体的新技术。将患有血小板抗体患者的血清加入到与O型正常血兼容的富血小板混合血浆中。与不含血清的相同富血小板血浆相比,肾上腺素和二磷酸腺苷(ADP)诱导的血小板聚集显著增加。添加血清的富血小板血浆不会自发聚集。当加入α-肾上腺素能阻滞剂(妥拉唑啉)时,无论富血小板血浆是否含有血清,肾上腺素诱导的初级聚集波均同样被逆转。尽管在我们的测试系统中血小板抗体本身不会凝集血小板,但血小板抗体很可能与血小板相互作用并增强其聚集能力。提示血小板聚集仪是体外检测血小板抗体的有用工具。

相似文献

1
Hyperaggregation effect in idiopathic thrombocytopenia and multiple transfused patients.特发性血小板减少症及多次输血患者中的高聚集效应。
J Clin Pathol. 1973 Sep;26(9):697-9. doi: 10.1136/jcp.26.9.697.
2
The assessment of drug-dependent and isoimmune antiplatelet antibodies by the use of platelet aggregometry.通过血小板聚集测定法评估药物依赖性和同种免疫性抗血小板抗体。
J Clin Invest. 1972 Dec;51(12):3142-53. doi: 10.1172/JCI107141.
3
Platelet dysfunction associated with immune-mediated thrombocytopenia in dogs.
J Vet Intern Med. 1994 Sep-Oct;8(5):323-7. doi: 10.1111/j.1939-1676.1994.tb03244.x.
4
Effect of phentolamine and propranolol an alpha and beta receptor blocking agent, on epinephrine and ADP induced platelet factor 3, platelet acid phosphatase availability and platelet factor 4 release.酚妥拉明和普萘洛尔(一种α和β受体阻滞剂)对肾上腺素和二磷酸腺苷诱导的血小板因子3、血小板酸性磷酸酶活性及血小板因子4释放的影响。
Acta Univ Carol Med Monogr. 1972;53:79-90.
5
Effects of bupranolol, a new beta-blocker, on platelet functions of rabbit and human in vitro.
Thromb Haemost. 1976 Nov 30;36(2):376-87.
6
Adhesion of human platelets to albumin is synergistically increased by lysophosphatidic acid and adrenaline in a donor-dependent fashion.溶血磷脂酸和肾上腺素以供体依赖的方式协同增加人血小板与白蛋白的黏附。
Blood Coagul Fibrinolysis. 2006 Jul;17(5):359-68. doi: 10.1097/01.mbc.0000233366.18605.b2.
7
Effects of adrenergic blockers on platelet aggregation.肾上腺素能阻滞剂对血小板聚集的影响。
Rev Esp Fisiol. 1979 Sep;35(3):269-72.
8
Platelet aggregation and PF3 availability induced by platelet antibodies in thromboasthenia.血小板无力症中血小板抗体诱导的血小板聚集及PF3有效性
Acta Univ Carol Med Monogr. 1972;53:291-6.
9
Characterization of platelet activation induced by HLA antibodies associated with alloimmune thrombocytopenia.与同种免疫性血小板减少症相关的HLA抗体诱导的血小板活化的特征
J Lab Clin Med. 1993 Mar;121(3):437-43.
10
Influence of mithramycin on some platelet functions in vitro.
Acta Haematol. 1980;63(2):101-6. doi: 10.1159/000207378.

本文引用的文献

1
The cause of thrombocytopenia in sedormid purpura.
Clin Sci. 1949 Dec 19;8(4):269-89, incl pl.
2
CHANGE IN PLATELET FACTOR 3 AS A MEANS OF DEMONSTRATING IMMUNE REACTIONS INVOLVING PLATELETS: ITS USE AS A TEST FOR QUINIDINE-INDUCED THROMBOCYTOPENIA.血小板第3因子的变化作为一种证明涉及血小板的免疫反应的手段:其作为奎尼丁诱导的血小板减少症检测方法的应用。
Transfusion. 1965 Jul-Aug;5:336-43. doi: 10.1111/j.1537-2995.1965.tb01182.x.
3
Aggregation of blood platelets by adenosine diphosphate and its reversal.二磷酸腺苷引起的血小板聚集及其逆转
Nature. 1962 Jun 9;194:927-9. doi: 10.1038/194927b0.
4
Thrombocytopenia with a circulating platelet agglutinin, platelet agglutinin, platelet lysin and clot retraction inhibitor.伴有循环血小板凝集素、血小板凝集素、血小板溶解素及血块回缩抑制剂的血小板减少症。
Blood. 1959 Feb;14(2):148-61.
5
Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura.特发性和新生儿血小板减少性紫癜的免疫机制
Ann Intern Med. 1953 Mar;38(3):433-69. doi: 10.7326/0003-4819-38-3-433.
6
In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus.特发性血小板减少性紫癜和系统性红斑狼疮患者血小板抗体的体外检测
Blood. 1969 Jun;33(6):795-812.
7
Qualitative platelet abnormalities in idiopathic thrombocytopenic purpura.
N Engl J Med. 1972 Mar 23;286(12):622-6. doi: 10.1056/NEJM197203232861202.
8
The assessment of drug-dependent and isoimmune antiplatelet antibodies by the use of platelet aggregometry.通过血小板聚集测定法评估药物依赖性和同种免疫性抗血小板抗体。
J Clin Invest. 1972 Dec;51(12):3142-53. doi: 10.1172/JCI107141.